N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons

J Neurosci. 2002 Feb 1;22(3):815-24. doi: 10.1523/JNEUROSCI.22-03-00815.2002.

Abstract

In most postmitotic neurons, expression or activation of proteins that stimulate cell cycle progression or DNA replication results in apoptosis. One potential exception to this generalization is neuroblastoma (NB), a tumor derived from the sympathoadrenal lineage. NBs often express high levels of N-myc, a proto-oncogene that can potently activate key components of the cell cycle machinery. Here, we show that in postmitotic sympathetic neurons, N-myc can induce S-phase entry while protecting neurons from death caused by aberrant cell cycle reentry. Specifically, these experiments demonstrate that expression of N-myc at levels similar to those in NBs caused sympathetic neurons to reenter S-phase, as monitored by 5-bromo-2-deoxyuridine incorporation and expression of cell cycle regulatory proteins, and rescued them from apoptosis induced by withdrawal of their obligate survival factor, nerve growth factor. The N-myc-induced cell cycle entry, but not enhanced survival, was inhibited by coexpression of a constitutively hypophosphorylated form of the retinoblastoma tumor suppressor protein, suggesting that these two effects of N-myc are mediated by separate pathways. In contrast, N-myc did not cause S-phase entry in postmitotic cortical neurons. Thus, N-myc both selectively causes sympathetic neurons to reenter the cell cycle and protects them from apoptosis, potentially contributing to their transformation to NBs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Bromodeoxyuridine
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Gene Expression / drug effects
  • Genetic Vectors / genetics
  • Genetic Vectors / metabolism
  • Humans
  • Mice
  • Mitosis / physiology
  • Nerve Growth Factor / pharmacology
  • Neuroblastoma* / etiology
  • Neuroblastoma* / genetics
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phosphorylation
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism*
  • Proto-Oncogene Proteins c-myc / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Retinoblastoma Protein / genetics
  • Retinoblastoma Protein / metabolism
  • Retinoblastoma Protein / pharmacology
  • S Phase / drug effects
  • S Phase / physiology*
  • Sympathetic Nervous System / cytology
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism*
  • Transfection

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc
  • Retinoblastoma Protein
  • Nerve Growth Factor
  • Bromodeoxyuridine